0.49
Schlusskurs vom Vortag:
$0.4756
Offen:
$0.4787
24-Stunden-Volumen:
5.31M
Relative Volume:
1.08
Marktkapitalisierung:
$388.46M
Einnahmen:
$22.39M
Nettoeinkommen (Verlust:
$-60.39M
KGV:
-4.3828
EPS:
-0.1118
Netto-Cashflow:
$-70.51M
1W Leistung:
-2.27%
1M Leistung:
-7.53%
6M Leistung:
+3.57%
1J Leistung:
+24.68%
Senseonics Holdings Inc Stock (SENS) Company Profile
Firmenname
Senseonics Holdings Inc
Sektor
Branche
Telefon
301-515-7260
Adresse
20451 Seneca Meadows Parkway, Germantown, MD
Vergleichen Sie SENS mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SENS
Senseonics Holdings Inc
|
0.49 | 388.46M | 22.39M | -60.39M | -70.51M | -0.1118 |
![]()
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
2025-04-10 | Eingeleitet | Mizuho | Outperform |
2023-07-19 | Eingeleitet | Jefferies | Underperform |
2021-08-19 | Eingeleitet | H.C. Wainwright | Buy |
2021-04-01 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2021-03-05 | Herabstufung | Raymond James | Mkt Perform → Underperform |
2021-01-21 | Herabstufung | BTIG Research | Buy → Neutral |
2021-01-20 | Herabstufung | Craig Hallum | Hold → Sell |
2020-08-11 | Hochstufung | BTIG Research | Neutral → Buy |
2020-08-11 | Hochstufung | Craig Hallum | Sell → Hold |
2020-03-13 | Herabstufung | BTIG Research | Buy → Neutral |
2020-03-13 | Herabstufung | Guggenheim | Buy → Neutral |
2019-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
2019-11-13 | Herabstufung | Craig Hallum | Buy → Hold |
2019-10-23 | Eingeleitet | Stifel | Buy |
2019-07-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
2019-01-29 | Eingeleitet | Piper Jaffray | Neutral |
2018-08-24 | Eingeleitet | Dougherty & Company | Buy |
Alle ansehen
Senseonics Holdings Inc Aktie (SENS) Neueste Nachrichten
Here's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 Weeks - Yahoo Finance
Analysts Offer Predictions for Senseonics FY2025 Earnings - Defense World
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst - GuruFocus
Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes - The Manila Times
Senseonics Holdings, Inc. to Host In-Person and Virtual - GlobeNewswire
Senseonics Unveils FDA-Approved 365-Day CGM System at ADA 2025 Analyst Event | SENS Stock News - Stock Titan
What is HC Wainwright’s Estimate for Senseonics Q2 Earnings? - Defense World
HC Wainwright Upgrades Senseonics (NYSE:SENS) to “Buy” - Defense World
Senseonics (NYSE:SENS) PT Set at $1.10 by HC Wainwright - Defense World
Senseonics (NYSE:SENS) Now Covered by Analysts at HC Wainwright - Defense World
H.C. Wainwright assumes Buy rating on Senseonics stock with $1.10 target - Investing.com
H.C. Wainwright assumes Buy rating on Senseonics stock with $1.10 target By Investing.com - Investing.com South Africa
Senseonics Holdings (SENS) Receives Buy Rating from HC Wainwright & Co. | SENS Stock News - GuruFocus
SENS Stock Gains Momentum with Unique Year-Long Glucose Monitoring System | SENS Stock News - GuruFocus
SENS Stock Gains Momentum with Unique Year-Long Glucose Monitori - GuruFocus
Senseonics Holdings announces underwritten public offering - MSN
Northern Trust Corp Buys 120,441 Shares of Senseonics Holdings, Inc. (NYSE:SENS) - Defense World
Continuous Glucose Monitoring Devices Market Forecast: Growth - openPR.com
Chief Medical Officer Kaufman Francine was granted 455,716 shares, increasing direct ownership by 21% to 2,599,910 units (SEC Form 4) - Quantisnow
Blood Glucose Monitoring Market Surges with Wearable Tech - openPR.com
Senseonics Raises $77.8 Million from Public Offering, Placement - marketscreener.com
Senseonics Holdings, Inc. Announces Closing of Public Offering, - GuruFocus
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement - The Manila Times
Senseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott Laboratories - Nasdaq
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement - GlobeNewswire
Senseonics Secures Massive $77.8M Funding Boost as Abbott Backs Next-Gen Diabetes Monitor Launch - Stock Titan
Diabetic Care Device Market Set for Significant Growth with 10.1% CAGR - GlobeNewswire Inc.
Senseonics Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity (NYSE:SENS) - Seeking Alpha
Senseonics announces pricing of $50 million public offering - MSN
Senseonics Holdings Announces Major Stock Offering Agreement - TipRanks
Constellation Brands, Senseonics, Estee Lauder - TradingView
Senseonics announces pricing of public offering of common stock - Medical Buyer
SENS: Key Developments and Market Insights | SENS Stock News - GuruFocus
Senseonics Prices $50 Million Public Offering - marketscreener.com
Senseonics (SENS) Launches $50 Million Stock Offering - GuruFocus
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement - citybiz
Senseonics Announces Pricing of $50 Million Public Offering of C - GuruFocus
Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement | SENS Stock News - GuruFocus
Senseonics Secures $50M Funding Boost: Abbott Takes Strategic Stake in Diabetes CGM Innovation - Stock Titan
Senseonics Announces Pricing Of $50 Million Public Offering At $0.50 Per Share - marketscreener.com
Senseonics Kicks Off $50 Million Stock Offering; Discloses Private Placement of Up to $25 Million With Abbott Laboratories - marketscreener.com
Senseonics (SENS) Launches Public Offering of Common Stock | SENS Stock News - GuruFocus
Senseonics launches public stock offering and private placement - Investing.com
Senseonics launches public stock offering and private placement By Investing.com - Investing.com Nigeria
Senseonics Holdings Inc Enters Securities Purchase Agreement With Abbott - marketscreener.com
Senseonics announces common stock offering, no amount given - TipRanks
Senseonics ticks down after announcing stock sale, private placement with Abbott - TradingView
Senseonics Holdings Enters Agreement with Abbott Laboratories - TipRanks
Senseonics Announces Commencement of $50 Million Public Offering - GuruFocus
Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement | SENS Stock News - GuruFocus
Finanzdaten der Senseonics Holdings Inc-Aktie (SENS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Senseonics Holdings Inc-Aktie (SENS) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
ROEDER DOUGLAS A | Director |
Dec 13 '24 |
Buy |
0.50 |
25,000 |
12,500 |
1,413,087 |
Sullivan Frederick T. | Chief Financial Officer |
Dec 12 '24 |
Buy |
0.38 |
124,933 |
47,475 |
2,478,844 |
Goodnow Timothy T | President and CEO |
Dec 10 '24 |
Buy |
0.31 |
315,000 |
97,650 |
11,310,355 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):